State of Tennessee, Department of Treasury’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-66,821
Closed -$296K 1749
2024
Q4
$296K Buy
66,821
+1,947
+3% +$7.9K ﹤0.01% 1552
2024
Q3
$267K Sell
64,874
-2,613
-4% -$14K ﹤0.01% 1570
2024
Q2
$440K Sell
67,487
-11,694
-15% -$82.7K ﹤0.01% 1431
2024
Q1
$690K Buy
79,181
+2,680
+4% +$32.5K ﹤0.01% 1283
2023
Q4
$875K Sell
76,501
-1,261
-2% -$12.5K ﹤0.01% 1239
2023
Q3
$749K Sell
77,762
-3,232
-4% -$31.7K ﹤0.01% 1167
2023
Q2
$862K Buy
80,994
+2,098
+3% +$22.5K ﹤0.01% 1219
2023
Q1
$830K Sell
78,896
-23,192
-23% -$260K ﹤0.01% 1185
2022
Q4
$1.26M Sell
102,088
-5,300
-5% -$60.1K 0.01% 1033
2022
Q3
$1.11M Buy
107,388
+63,327
+144% +$718K 0.01% 1041
2022
Q2
$508K Buy
+44,061
New +$519K ﹤0.01% 1329

Other funds holding IRWD

State of Tennessee, Department of Treasury's IRWD Position: Q1 2025 in Review

State of Tennessee, Department of Treasury sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 66,821 shares — an estimated $296K sold.

State of Tennessee, Department of Treasury first reported a position in IRWD in Q2 2022 and held it in 11 quarters. The position peaked at $1.26M in Q4 2022. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • State of Tennessee, Department of Treasury reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 66,821 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $296K.
  • State of Tennessee, Department of Treasury first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • State of Tennessee, Department of Treasury's Ironwood Pharmaceuticals position peaked at $1.26M in Q4 2022.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2025, filed 13 May 2025.